IRCT2017040533244N1已完成未知
Comparison of the Efficacy of Hydroquinone 2% cream versus Tranexamic Acid Injection in Treatment of Melasema
Deputy of Research and Technology of Shiraz University of Medical Sciences0 个研究点目标入组 37 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients with melasma
- •Exclusion criteria: Patients treated with steroids; Hydroquinone; Tretinoin; Azaleacic Acid and Kojic Acid; or pregnant; will be excluded. In addition, patients who have taken OCP over the past 12 months and who are taking light-sensitive drugs such as tetracycline; spironolactone; phenytoin and carbamazepine; or coagulation disorders and taking anticoagulant drugs will also be excluded.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Combination of Hydroquinone and Fractional CO2 Laser vs. Hydroquinone Monotherapy in Melasma Treatment: A Randomized Split-face Clinical TrialChloasmaIRCT20171222037987N1Esfahan University of Medical Sciences40
招募中
2 期
evaluating effectivness of Plasma rich in growth factor (PRGF) in the treatment of melasmaIRCT20221016056188N1Kerman University of Medical Sciences20
招募中
1 期
The effectiveness of hydroquinone 4% versus hydroquinone 4% with intradermal injection of autologous platelet-rich plasma in the treatment of lichen planus pigmentosus: A comparative split-face clinical trialichen planus pigmentosus of the face or neck for 6 months or longer that has been confirmed by histopathology.lichen planus pigmentosus, hydroquinone, autologous platelet-rich plasmaTCTR20240430003Institute of Dermatology, Bangkok, Thailand15
已完成
2 期
treatment of melasmamelasma.ChloasmaIRCT2014110919885N1Vice Chancellor for Researc?h, Hamadan university of medical science44
招募中
4 期
Comparative study between topical hydroquinone 4% alone versus its combination with intradermal autologous platelet-rich plasma in the treatment of melasma: a split-face controlled trialMelasmamelasma, autologous platelet-rich plasma, hydroquinoneTCTR20210925002Institute of Dermatology20